Position in GILD
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$482,239
-$324,852 QoQ
Shares Held
3,817
-34.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,386
of 2,266 holders
Holding Since
Dec 2022
7 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calamos Wealth Management LLC holds $79,224,350 across 11 Drug Manufacturers - General names. GILD ranks #9 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
31,177 | $37,394,632 | |
| 2 | JNJ |
Johnson & Johnson
|
118,126 | $30,000,460 | |
| 3 | ABBV |
AbbVie Inc.
|
15,919 | $4,005,857 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,811 | $2,674,213 | |
| 5 | PFE |
Pfizer Inc
|
65,212 | $1,570,304 | |
| 6 | AMGN |
Amgen Inc
|
2,408 | $871,984 | |
| 7 | AZN |
Astrazeneca PLC
|
4,208 | $797,920 | |
| 8 | NVS |
Novartis AG
|
4,898 | $767,614 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $482,239 | 3,817 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $807,091 | 5,791 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $379,512 | 3,092 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $393,828 | 3,548 | Shares | Sole | 2025-10-20 | |
| 2023-06-30 | $341,265 | 4,428 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $344,408 | 4,151 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $372,503 | 4,339 | Shares | Sole | 2023-01-26 | |
| No filing history on record for this holder in this stock. | ||||||